Therazymes Pharmaceuticals Private Limited
Manufactures bulk drugs and pharmaceuticals since 2018 in Telangana.
2018 | Hyderabad, Telangana (India) | Active
Therazymes Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -28.33%
- Ebitda
- Net Worth -29.65%
- Total Assets -16.98%
About Therazymes Pharmaceuticals
Therazymes Pharmaceuticals Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 October 2018 (Six years and four months 27 days old ). Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Tzymes Technologies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sreenivasulu Mallu and Dayakar Mallu serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2018PTC127392
- Company No.
127392
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Therazymes Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreenivasulu Mallu  | Director | 04-Oct-2018 | Current |
Dayakar Mallu  | Director | 04-Oct-2018 | Current |
Financial Performance of Therazymes Pharmaceuticals.
Therazymes Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 28.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 29.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Therazymes Pharmaceuticals?
In 2023, Therazymes Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Lakshmi Infra Projects Llp
Sreenivasulu Mallu is a mutual person
- Vinta Laboratories Private Limited
Sreenivasulu Mallu and Dayakar Mallu are mutual person
- Therazymes Private Limited
Sreenivasulu Mallu and Dayakar Mallu are mutual person
- Castlestone Ventures Private Limited
Sreenivasulu Mallu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Therazymes Pharmaceuticals?
Unlock and access historical data on people associated with Therazymes Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Therazymes Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Therazymes Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.